featured
Tralokinumab Treatment Improves the Skin Microbiota by Increasing the Microbial Diversity in Adults With Moderate to Severe Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial
J Am Acad Dermatol 2022 Dec 05;[EPub Ahead of Print], LA Beck, T Bieber, S Weidinger, M Tauber, H Saeki, AD Irvine, LF Eichenfield, T Werfel, P Arlert, L Jiang, M Røpke, AS PallerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.